BRISTOL MYERS SQUIBB CO
S-8, 1998-03-05
PHARMACEUTICAL PREPARATIONS
Previous: BOND FUND OF AMERICA INC, 497J, 1998-03-05
Next: BROWN & SHARPE MANUFACTURING CO /DE/, 8-K, 1998-03-05




<PAGE>

<PAGE>




                                                    Registration No. ___ - _____

     As filed with the Securities and Exchange Commission on March 5, 1998

================================================================================

                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                              --------------------

                                    FORM S-8

                             REGISTRATION STATEMENT
                                      Under
                           THE SECURITIES ACT OF 1933

                              --------------------


                          BRISTOL-MYERS SQUIBB COMPANY
               (Exact name of issuer as specified in its charter)

           Delaware                                      22-0790350
   (State of Incorporation)                 (I.R.S. Employer Identification No.)

                                 345 Park Avenue
                            New York, New York 10154
                                 (212) 546-4000
          (Address and telephone number of principal executive offices)

                          BRISTOL-MYERS SQUIBB COMPANY
                            1997 STOCK INCENTIVE PLAN
                          (EFFECTIVE AS OF MAY 6, 1997)

                          BRISTOL-MYERS SQUIBB COMPANY
                             1983 STOCK OPTION PLAN
                            (AS AMENDED AND RESTATED
                       EFFECTIVE AS OF SEPTEMBER 10, 1996)
                              (Full title of Plans)

                              --------------------

                               John L. McGoldrick
     Senior Vice President, Law and Strategic Planning, and General Counsel
                          Bristol-Myers Squibb Company
                                 345 Park Avenue
                            New York, New York 10154
                                 (212) 546-4000
            (Name, address and telephone number of agent for service)

                              --------------------

                                   Copies to:

        Alice Brennan                            Scott Applebaum
Vice President and Secretary        Assistant Counsel, Corporate Human Resources
Bristol-Myers Squibb Company                Bristol-Myers Squibb Company
       345 Park Avenue                         777 Scudders Mill Road
  New York, New York 10154                  Plainsboro, New Jersey 08536
       (212) 546-4000                            (609) 897-2000
                              --------------------

                     CALCULATION OF REGISTRATION FEE

<TABLE>
<CAPTION>
=========================================================================================================================
                                                          Proposed Maximum      Proposed Maximum
                                       Amount to be       Offering Price Per    Aggregate Offering    Amount
Title of Securities to be Registered   Registered         Share(1)              Price(1)              Registration Fee(1)
- -------------------------------------------------------------------------------------------------------------------------
<S>                                    <C>                <C>                   <C>                   <C> 
Common Stock, par value $.10 per  
share.............................     20,000,000         $100.21875             $2,437,500,000       $591,290.62
=========================================================================================================================

</TABLE>

- ------------------
(1)  Pursuant to Rule 457(h) and Rule 457(c), the proposed maximum offering
     price per share and the registration fee are based on the reported average
     of the high and low prices for Bristol-Myers Squibb Company Common Stock
     as reported on the New York Stock Exchange on February 26, 1998.



<PAGE>

<PAGE>





                                     PART I

               INFORMATION REQUIRED IN A SECTION 10(a) PROSPECTUS

Item 1.  PLAN INFORMATION

Item 2.  REGISTRANT INFORMATION AND EMPLOYEE PLAN ANNUAL INFORMATION

                                     PART II

               INFORMATION REQUIRED IN THIS REGISTRATION STATEMENT

ITEM 3.  INCORPORATION OF DOCUMENTS BY REFERENCE.

        The following documents which have heretofore been filed by
Bristol-Myers Squibb Company (the "Company") (File No. 001-01136) with the
Securities and Exchange Commission (the "Commission") pursuant to the Securities
Exchange Act of 1934, as amended (the "1934 Act"), are incorporated by reference
herein and shall be deemed to be a part hereof:

                  1.    The Company's Annual Report on Form 10-K for the fiscal
                        year ended December 31, 1996;

                  2.    The Company's Quarterly Reports on Form 10-Q for the
                        quarters ended March 31, 1997, June 30, 1997, and
                        September 30, 1997;

                  3.    The description of the Company's Common Stock contained
                        in a Registration Statement filed under the 1934 Act,
                        including any amendment or report filed for the purpose
                        of updating such description; and

                  4.    The contents of the Company's Registration Statement
                        on Form S-8 (Registration No. 33-52691) filed with
                        the Commission on March 16, 1994.

        All documents filed by the Company with the Commission pursuant to
Sections 13(a), 13(c), 14 and 15(d) of the 1934 Act prior to the filing of a
post-effective amendment to this Registration Statement which indicates that all
securities offered have been sold or which deregisters all securities then
remaining unsold shall be deemed to be incorporated by reference in this
Registration Statement and made a part hereof from their respective dates of
filing (such documents, and the documents enumerated above, being hereinafter
referred to as "Incorporated Documents"); provided, however, that the documents
enumerated above or subsequently filed by the Company pursuant to Sections
13(a), 13(c), 14 and 15(d) of the 1934 Act in each year during which the
offering made by this Registration Statement is in effect prior to the filing
with the Commission of the Company's Annual Report on Form 10-K covering such
year shall not be Incorporated Documents or be incorporated by reference in this
Registration Statement or be a part hereof from and after the filing of such
Annual Report on Form 10-K.

        Any statement contained in an Incorporated Document shall be deemed to
be modified or superseded for purposes of this Registration Statement to the
extent that a statement contained herein or in any other subsequently filed
Incorporated Document modifies or supersedes such statement. Any such

                                       -2-


<PAGE>

<PAGE>





statement so modified or superseded shall not be deemed, except as so modified
or superseded, to constitute a part of this Registration Statement.

ITEM 4.  DESCRIPTION OF SECURITIES.

                  See Item 3.

ITEM 5.  INTERESTS OF NAMED EXPERTS AND COUNSEL.

        The legality of the Common Stock offered pursuant to this Registration
Statement has been passed upon for the Company by John L. McGoldrick, Senior
Vice President, Law and Strategic Planning, and General Counsel of the Company,
345 Park Avenue, New York, New York 10154. Mr. McGoldrick is an officer of the
Company and owns, and has options to purchase, shares of common stock of the
Company.

ITEM 6.  INDEMNIFICATION OF DIRECTORS AND OFFICERS.

        Section 145 of the Delaware General Corporation Law (the "DGCL")
provides that a corporation may indemnify directors and officers as well as
other employees and individuals against expenses (including attorneys' fees),
judgments, fines and amounts paid in settlement in connection with specified
actions, suits or proceedings, whether civil, criminal, administrative or
investigative (other than an action by or in the right of the corporation - a
"derivative action"), if they acted in good faith and in a manner they
reasonably believed to be in or not opposed to the best interests of the
corporation and, with respect to any criminal actions or proceedings, had no
reasonable cause to believe their conduct was unlawful. A similar standard is
applicable in the case of derivative actions, except that indemnification only
extends to expenses (including attorneys' fees) actually and reasonably incurred
in connection with the defense or settlement of such action, and the DGCL
requires court approval before there can be any indemnification where the person
seeking indemnification has been found liable to the corporation. The DGCL
provides that it is not exclusive of other indemnification that may be granted
by a corporation's by-laws, disinterested director vote, stockholder vote,
agreement or otherwise.

        Under the terms of the Company's Bylaws and subject to the applicable
provisions of the laws of the State of Delaware, the Company has indemnified
each of its directors and officers, and any employee of the Company who, at the
Company's request, has served as a director or officer of another corporation in
which the Company owns capital or of which it is a creditor, against expenses
incurred or paid in connection with any claim made against such director or
officer or any actual or threatened action, suit or proceeding in which such
director or officer may be involved by reason of being or having been a director
or officer of the Company, or of serving or having served at the request of the
Company as a director, officer, employee or agent of another corporation,
partnership, joint venture, trust or other enterprise, or by reason of any
action taken or not taken by such director or officer in such capacity, and
against the amount or amounts paid by such director or officer in settlement of
any such claim, action, suit or proceeding or any judgment or order entered
therein.

        Section 102(b)(7) of the DGCL permits a provision in the certificate of
incorporation of each corporation organized thereunder, such as the Company,
eliminating or limiting, with certain exceptions, the personal liability of a
director to the corporation or its stockholders for monetary damages for breach
of fiduciary duty as a director. The Restated Certificate of Incorporation of
the Company eliminates the liability of directors to the extent permitted by the
DGCL.

                                       -3-


<PAGE>

<PAGE>





        The Company carries directors' and officers' liability insurance that
covers certain liabilities and expenses of the Company's directors and officers.

ITEM 7.  EXEMPTION FROM REGISTRATION CLAIMED.

                  Not applicable.

ITEM 8.  EXHIBITS.

<TABLE>
<CAPTION>

   Exhibit Number                                    Description
   --------------                                    ------------
         <S>           <C>
         4(a)     -    Restated Certificate of Incorporation of Bristol-Myers Squibb Company
                       (filed as Exhibit 4(a) to the Registrant's Registration Statement on Form
                       S-3, Registration No. 33-33682, dated March 7, 1990) as amended
                       through May 6, 1997.*

         4(b)     -    Bylaws of the Registrant, as amended through November 5, 1996 (filed
                       as Exhibit 3(b) to the Registrant's Annual Report on Form 10-K, File
                       No. 001-01136, for the fiscal year ended December 31, 1996)* as amended
                       through January 1, 1998.

         5        -    Opinion of the Registrant's General Counsel as to the legality of
                       securities offered under the Bristol-Myers Squibb Company 1997 Stock
                       Incentive Plan, effective as of May 6, 1997 and the Bristol-Myers Squibb
                       Company 1983 Stock Option Plan, as amended and restated effective as of
                       September 10, 1996.

         23(a)    -    Consent of Independent Accountants, Price Waterhouse LLP.

         23(b)    -    Consent of Counsel (contained in the Opinion of the Registrant's
                       General Counsel, Exhibit 5 hereto).

         99(a)    -    Bristol-Myers Squibb Company 1997 Stock Incentive Plan, effective as
                       of May 6, 1997 and amended through December 2, 1997.

         99(b)    -    Bristol-Myers Squibb Company 1983 Stock Option Plan, as
                       amended and restated effective as of September 10, 1996
                       (filed as Exhibit 10c to the Registrant's Annual Report
                       on Form 10-K, File No. 001-01136, for the fiscal year
                       ended December 31, 1996).*
</TABLE>


- ------------------------------
*  Incorporated by reference

                                       -4-


<PAGE>

<PAGE>





ITEM 9.  UNDERTAKINGS.

        (1) The undersigned Registrant hereby undertakes:

                  (a) to file, during any period in which offers or sales are
being made, a post-effective amendment to this Registration Statement:

                           (i)    To include any prospectus required by Section
                                  10(a)(3) of the Securities Act of 1933;

                           (ii)   To reflect in the prospectus any facts or
                                  events arising after the effective date of
                                  this Registration Statement (or the most
                                  recent post-effective amendment thereof)
                                  which, individually or in the aggregate,
                                  represent a fundamental change in the
                                  information set forth in this Registration
                                  Statement;

                           (iii)  To include any material information with
                                  respect to the plan of distribution not
                                  previously disclosed in this Registration
                                  Statement or any material change to such
                                  information in this Registration Statement;

                  Provided, however, that paragraphs (1)(a)(i) and (1)(a)(ii) do
not apply if the registration statement is on Form S-3 or Form S-8 and the
information required to be included in a post-effective amendment by those
paragraphs are contained in periodic reports filed by the Registrant pursuant to
Section 13(a) or Section 15(d) of the 1934 Act that are incorporated by
reference in the registration statement:

                  (b) That, for the purpose of determining any liability under
the Securities Act of 1933, each such post-effective amendment shall be deemed
to be a new Registration Statement relating to the securities offered therein,
and the offering of such securities at that time shall be deemed to be the
initial bona fide offering thereof; and

                  (c) To remove from registration by means of a post-effective
amendment any of the securities being registered which remain unsold at the
termination of the offering.

         (2) The undersigned Registrant hereby undertakes that, for the purpose
of determining any liability under the Securities Act of 1933, each filing of
the issuer's annual report pursuant to Section 13(a) or 15(d) of the Securities
Exchange Act of 1934 (and, where applicable, each filing of an employee benefit
plan's annual report pursuant to Section 15(d) of the Securities Exchange Act of
1934) that is incorporated by reference in this Registration Statement shall be
deemed to be a new Registration Statement relating to the securities offered
therein and the offering of such securities at the time shall be deemed to be
the initial bona fide offering thereof.

         (3) Insofar as indemnification for liabilities arising under the
Securities Act of 1933 may be permitted to directors, officers and controlling
persons of the Registrant pursuant to the foregoing provisions, or otherwise,
the Registrant has been advised that in the opinion of the Commission such
indemnification is against public policy as expressed in the Act and is,
therefore, unenforceable. In the event that a claim for indemnification against
such liabilities (other than the payment by the Registrant of

                                       -5-


<PAGE>

<PAGE>





expenses incurred or paid by a director, officer or controlling person of the
Registrant in the successful defense of any action, suit or proceeding) is
asserted by such director, officer or controlling person in connection with the
securities being registered, the Registrant will, unless in the opinion of its
counsel the matter has been settled by controlling precedent, submit to a court
of appropriate jurisdiction the question whether such indemnification by it is
against public policy as expressed in the Act and will be governed by the final
adjudication of such issue.

                                     EXPERTS

         The financial statements incorporated in the Prospectus constituting
part of this Registration Statement by reference to the Annual Report on Form
10-K of Bristol-Myers Squibb Company for the year ended December 31, 1996, have
been so incorporated in reliance on the report of Price Waterhouse LLP,
independent accountants, given on the authority of said firm as experts in
auditing and accounting.

                                   SIGNATURES

         Pursuant to the requirements of the Securities Act of 1933, the
Registrant certifies that it has reasonable grounds to believe that it meets all
of the requirements for filing on Form S-8 and has duly caused this Registration
Statement to be signed on its behalf by the undersigned, thereunto duly
authorized, in the City of New York, and the State of New York, on the 3rd day
of March, 1998.

                                        BRISTOL-MYERS SQUIBB COMPANY

                                        By:            *
                                            ------------------------------------
                                                (Charles A. Heimbold, Jr.,
                                                   Chairman of the Board,
                                           Chief Executive Officer and Director)

* Signed on behalf of Charles A. Heimbold, Jr. by Charles G. Tharp pursuant
  to the power of attorney executed by Charles A. Heimbold, Jr. included
  herewith.

                                       -6-


<PAGE>

<PAGE>



                             POWER OF ATTORNEY

         Each person whose signature appears below hereby severally constitutes
and appoints Charles G. Tharp and each of them acting singly, as his or her true
and lawful attorney-in-fact and agent, with full and several power of
substitution and resubstitution, to sign for him or her and in his or her name,
place and stead, in any and all capacities indicated below, the registration
statement on Form S-8 filed herewith and any and all pre-effective and
post-effective amendments and supplements to said registration statement, and
to file the same, with all exhibits thereto, and other documents in connection
therewith, with the Securities and Exchange Commission, granting unto said
attorney-in-fact and agent full power and authority to do and perform each and
every act and thing requisite and necessary fully to all intents and purposes
as he or she might or could do in person, hereby ratifying and confirming all
that said attorney-in-fact and agent or his or her substitute, may lawfully
do or cause to be done by virtue thereof.

         Pursuant to the requirements of the Securities Act of 1933, this
registration statement has been signed below by the following persons in the
capacities indicated on March 3, 1998.


Signature                          Title
- ---------                          -----

/s/ Charles A. Heimbold, Jr.
- ------------------------------     Chairman of the Board,
(Charles A. Heimbold, Jr.)         Chief Executive Officer and Director
                                   (Principal Executive Officer)


- ------------------------------     Executive Vice President and
(Kenneth E. Weg)                   Director

/s/ Michael F. Mee
- ------------------------------     Senior Vice President and
(Michael F. Mee)                   Chief Financial Officer

/s/ Frederick S. Schiff
- ------------------------------     Corporate Staff Vice President, 
(Frederick S. Schiff)              Financial Operations and Controller
                                   (Principal Accounting Officer)

/s/ Robert E. Allen
- ------------------------------     Director
(Robert E. Allen)


- ------------------------------     Director
(Vance D. Coffman)

/s/ Ellen V. Futter
- ------------------------------     Director
(Ellen V. Futter)

/s/ Louis V. Gerstner, Jr.
- ------------------------------     Director
(Louis V. Gerstner, Jr.)

/s/ Laurie H. Glimcher, M.D.
- ------------------------------     Director
(Laurie H. Glimcher, M.D.)

/s/ John D. Macomber
- ------------------------------     Director
(John D. Macomber)

/s/ James D. Robinson, III
- ------------------------------     Director
(James D. Robinson III)

/s/ Andrew C. Sigler
- ------------------------------     Director
(Andrew C. Sigler)

/s/ Louis W. Sullivan, M.D.
- ------------------------------     Director
(Louis W. Sullivan, M.D.)

                                       -7-



<PAGE>

<PAGE>





                          Bristol-Myers Squibb Company

                            -------------------------

                                  Exhibit Index

Exhibit                                                               Sequential
Number                             Description                       Page Number
- -------                            -----------                       -----------
4(a)        Restated Certificate of Incorporation of
            Bristol-Myers Squibb Company (filed as
            Exhibit 4(a) to the Registrant's Registration
            Statement on Form S-3, Registration No.
            33-33682, dated March 7, 1990), as
            amended through May 6, 1997.*

4(b)        Bylaws of the Registrant, as amended
            through November 5, 1996 (filed as Exhibit
            3(b) to the Registrant's Annual Report on
            Form 10-K, File No. 001-01136, for the
            fiscal year ended December 31, 1996)*
            as amended through January 1, 1998.

5           Opinion of the Registrant's General
            Counsel as to the legality of securities
            offered under the Bristol-Myers Squibb
            Company 1997 Incentive Stock Plan,
            effective as of May 6, 1997 and the 
            Bristol-Myers Squibb 1983 Stock Option
            Plan, as amended and restated effective
            as of September 10, 1996.

23(a)       Consent of Independent Accountants, Price
            Waterhouse LLP.

23(b)       Consent of Counsel (contained in the
            Opinion of the Registrant's General
            Counsel, Exhibit 5 hereto).

99(a)       Bristol-Myers Squibb Company 1997
            Incentive Stock Plan, effective as of May 6,
            1997 and amended through December 2,
            1997.

99(b)       Bristol-Myers Squibb Company 1983 Stock
            Option Plan, as amended and restated effective
            as of September 10, 1996 (filed as Exhibit 10c
            to the Registrant's Annual Report on Form 10-K,
            File No. 001-01136, for the fiscal year ended
            December 31, 1996).* 
            
- -----------------------------------
*  Incorporated by reference

                                       -2-

<PAGE>


<PAGE>

                          CERTIFICATE OF AMENDMENT
                                     OF
                                   BYLAWS


        Bristol-Myers Squibb Company, a corporation organized and existing
under and by virtue of the General Corporation Law of the State of Delaware,
DOES HEREBY CERTIFY:

        That at a meeting of the Board of Directors of December 17, 1997 a
resolution was duly adopted setting forth an amendment to the Bylaws of the
corporation. The resolution setting forth the amendment is as follows:

                RESOLVED, that effective January 1, 1998, the first
                sentence of Section (a) of Bylaw No. 15 of the Company
                be, and hereby is, amended to read in full as follows:

                        'The Board of Directors shall
                        consist of eleven directors.'

        IN WITNESS WHEREOF, said corporation has caused this certificate to
be signed by Alice C. Brennan, its Vice President and Secretary, this
2nd day of March, 1998.


                                               By: /s/ Alice C. Brennan
                                                   --------------------------
                                                   Alice C. Brennan
                                                   Vice President & Secretary

<PAGE>


<PAGE>

                                    EXHIBIT 5

                                                               March 3, 1998

Bristol-Myers Squibb Company
345 Park Avenue
New York, New York  10154

         Re:       Bristol-Myers Squibb Company - Registration Statement on
                   Form S-8 relating to the Bristol-Myers Squibb Company
                   1997 Stock Incentive Plan, effective as of May 6,
                   1997 and the Bristol-Myers Squibb Company 1983 Stock
                   Option Plan, as amended and restated effective as of
                   September 10, 1996  (the "Registration Statement"). 
                   ---------------------------------------------------------

Gentlemen:

     In connection with the proposed sale of up to 20,000,000 shares of the
common stock par value $.10 (the "Shares") of Bristol-Myers Squibb Company (the
"Company") pursuant to the Bristol-Myers Squibb Company 1997 Stock Incentive
Plan and the Bristol-Myers Squibb Company 1983 Stock Option Plan (the "Plans")
with respect to which a Registration Statement on Form S-8 has been prepared for
filing with the Securities and Exchange Commission pursuant to the Securities
Act of 1933, I have examined or supervised the examination of such corporate
records, other documents and questions of law as I considered necessary for the
purpose of this opinion.

     I am of the opinion that when:

     (a)  the applicable provisions of the Securities Act of 1933 and of State
          securities "blue sky" laws shall have been complied with;

     (b)  the Company's Board of Directors shall have duly authorized the issue
          and sale of the Shares; and

     (c)  the Shares shall have been duly issued and paid for (in an amount not
          less than $.10 par value thereof);

     the Shares will be legally issued, fully paid and nonassessable.

     I hereby consent to the use of this opinion as an Exhibit to the
Registration Statement on Form S-8 and to the reference to me under the caption
"Legal Opinion" in the Registration Statement and related Prospectus, and any
amendments thereto, filed or distributed in connection with the Plans.

                                                  Very truly yours,

                                                  /s/ John L. McGoldrick
                                                  ------------------------------
                                                  John L. McGoldrick
                                                  General Counsel


<PAGE>




<PAGE>



                                  EXHIBIT 23(a)

                       CONSENT OF INDEPENDENT ACCOUNTANTS

     We hereby consent to the incorporation by reference in the Prospectus
constituting part of this Registration Statement on Form S-8 of our report dated
January 22, 1997 appearing on page 53 of the Bristol-Myers Squibb Company's
Annual Report on Form 10-K for the year ended December 31, 1996. We also consent
to the reference to us under the heading "Experts" in such Prospectus.


                                                /s/ PRICE WATERHOUSE LLP
                                                --------------------------------
                                                PRICE WATERHOUSE LLP

<PAGE>




<PAGE>



                                                                       EXHIBIT B
 
                          BRISTOL-MYERS SQUIBB COMPANY
                           1997 STOCK INCENTIVE PLAN
 
     1. PURPOSE: The purpose of the 1997 Stock Incentive Plan is to secure for
the Company and its stockholders the benefits of the incentive inherent in
common stock ownership by the officers and key employees of the Company and its
Subsidiaries and Affiliates who will be largely responsible for the Company's
future growth and continued financial success and by providing long-term
incentives in addition to current compensation to certain key executives of the
Company and its Subsidiaries and Affiliates who contribute significantly to the
long-term performance and growth of the Company and such Subsidiaries and
Affiliates. It is intended that the former purpose will be effected through the
granting of stock options, stock appreciation rights, dividend equivalents
and/or restricted stock under the Plan and that the latter purpose will be
effected through an award conditionally granting performance units or
performance shares under the Plan, either independently or in conjunction with
and related to a nonqualified stock option grant under the Plan.
 
     2. DEFINITIONS: For purposes of this Plan:
 
          (a) 'Affiliate' shall mean any entity in which the Company has an
     ownership interest of at least 20%.
 
          (b) 'Code' shall mean the Internal Revenue Code of 1986, as amended.
 
          (c) 'Common Stock' shall mean the Company's common stock (par value
     $.10 per share).
 
          (d) 'Company' shall mean the Issuer (the Bristol-Myers Squibb
     Company), its Subsidiaries and Affiliates.
 
          (e) 'Disability' or 'Disabled' shall mean qualifying for and receiving
     payments under a disability pay plan of the Company or any Subsidiary or
     Affiliate.
 
          (f) 'Exchange Act' shall mean the Securities Exchange Act of 1934, as
     amended.
 
          (g) 'Fair Market Value' shall mean the average of the high and low
     sale prices of a share of Common Stock on the New York Stock Exchange, Inc.
     composite tape on the date of measurement or on any date as determined by
     the Committee and if there were no trades on such date, on the day on which
     a trade occurred next preceding such date.
 
          (h) 'Issuer' shall mean the Bristol-Myers Squibb Company.
 
          (i) 'Prior Plan' shall mean the Bristol-Myers Squibb Company 1983
     Stock Option Plan as amended and restated effective as of September 10,
     1996.
 
          (j) 'Retirement' shall mean termination of the employment of an
     employee with the Company or a Subsidiary or Affiliate on or after (i) the
     employee's 65th birthday or (ii) the employee's 55th birthday if the
     employee has completed 10 years of service with the Company, its
     Subsidiaries and/or its Affiliates. For purposes of this Section 2(j) and
     all other purposes of this Plan, Retirement shall also mean termination of
     employment of an employee with the Company or a Subsidiary or Affiliate for
     any reason (other than the employee's death, disability, resignation,
     willful misconduct or activity deemed detrimental to the interests of the
     Company) where, on termination, the employee's age plus years of service
     (rounded up to the next higher whole number) equals at least 70 and the
     employee has completed 10 years of service with the Company, its
     Subsidiaries and/or its Affiliates.
 
          Furthermore, an employee who makes an election to retire under Article
     19 of the Bristol-Myers Squibb Company Retirement Income Plan (the
     'Retirement Income Plan') shall have any additional years of age and
     service which are credited under Article 19 of the Retirement Income Plan
     taken into account when determining such employee's age and service under
     this Section 2(j). Such election shall be deemed a Retirement for purposes
     of this Section 2(j) and all other purposes of this Plan.
 
                                      B-1
 
<PAGE>

<PAGE>


          (k) 'Subsidiary' shall mean any corporation which at the time
     qualifies as a subsidiary of the Company under the definition of
     'subsidiary corporation' in Section 424 of the Code.
 
     3. AMOUNT OF STOCK: The amount of stock which may be made subject to grants
of options or awards of performance units under the Plan in calendar year 1997
shall not exceed an amount equal to the amount of shares available for, and not
made subject to, grants of options or awards under the Prior Plan as of February
28, 1997. With respect to each succeeding year, the amount of stock which may be
made subject to grants of options or awards of performance units under the Plan
shall not exceed an amount equal to (i) 0.9% of the outstanding shares of the
Company's Common Stock on January 1 of such year plus, subject to this Section
3, (ii) in any year the number of shares equal to the amount of shares that were
available for grants and awards in the prior year but were not made subject to a
grant or award in such prior year and (iii) the number of shares that were
subject to options or awards granted hereunder or under the Prior Plan, which
options or awards terminated or expired in the prior year without being
exercised. No individual may be granted options or awards under Sections 6, 7 or
8 in the aggregate, in respect of more than 1,500,000 shares of the Company's
Common Stock in a calendar year; upon a change in stock the maximum number of
shares shall be adjusted in number and kind pursuant to Section 10. Aggregate
shares issued under performance share awards made pursuant to Section 7 and
restricted stock awards made pursuant to Section 8 may not exceed 10,000,000
shares over the life of the Plan. Common Stock issued hereunder may be
authorized and reissued shares or issued shares acquired by the Company or its
Subsidiaries on the market or otherwise.
 
     4. ADMINISTRATION: The Plan shall be administered under the supervision of
the Board of Directors of the Company which shall exercise its powers, to the
extent herein provided, through the agency of a Compensation and Management
Development Committee (the 'Committee') which shall be appointed by the Board of
Directors of the Company. The Committee shall consist of not less than three (3)
members of the Board who meet the definition of 'outside director' under the
provisions of Section 162(m) of the Code and the definition of 'non-employee
directors' under the provisions of the Exchange Act or rules or regulations
promulgated thereunder. No member of the Committee shall have been within one
year prior to appointment to, or while serving on, the Committee granted or
awarded equity securities of the Company pursuant to this or any other plan of
the Company except to the extent that participation in any such plan or receipt
of any such grant or award would not adversely affect the Committee member's
status as a 'nonemployee director' or as an 'outside director'.
 
     The Committee, from time to time, may adopt rules and regulations
('Regulations') for carrying out the provisions and purposes of the Plan and
make such other determinations, not inconsistent with the terms of the Plan, as
the Committee shall deem appropriate. The interpretation and construction of any
provision of the Plan by the Committee shall, unless otherwise determined by the
Board of Directors, be final and conclusive.
 
     The Committee shall maintain a written record of its proceedings. A
majority of the Committee shall constitute a quorum, and the acts of a majority
of the members present at any meeting at which a quorum is present, or acts
unanimously approved in writing, shall be the acts of the Committee.
 
     5. ELIGIBILITY: Options and awards may be granted only to present or future
officers and key employees of the Company and its Subsidiaries and Affiliates,
including Subsidiaries and Affiliates which become such after the adoption of
the Plan. Any officer or key employee of the Company or of any such Subsidiary
or Affiliate shall be eligible to receive one or more options or awards under
the Plan. Any director who is not an officer or employee of the Company or one
of its Subsidiaries or Affiliates and any member of the Committee, during the
time of the member's service as such or thereafter, shall be ineligible to
receive an option or award under the Plan. The adoption of this Plan shall not
be deemed to give any officer or employee any right to an award or to be granted
an option to purchase Common Stock of the Company, except to the extent and upon
such terms and conditions as may be determined by the Committee.
 
     6. STOCK OPTIONS: Stock options under the Plan shall consist of incentive
stock options under Section 422 of the Code or nonqualified stock options
(options not intended to qualify as incentive stock options), as the Committee
shall determine. In addition, the Committee may grant stock appreciation rights
in conjunction with an option, as set forth in Section 6(b)(11), or may grant
awards in conjunction with an option, as set forth in Section 6(b)(10) (an
'Associated Option').
 
                                      B-2
 
<PAGE>

<PAGE>


     Each option shall be subject to the following terms and conditions:
 
          (a) Grant of Options. The Committee shall (1) select the officers and
     key employees of the Company and its Subsidiaries and Affiliates to whom
     options may from time to time be granted, (2) determine whether incentive
     stock options or nonqualified stock options are to be granted, (3)
     determine the number of shares to be covered by each option so granted, (4)
     determine the terms and conditions (not inconsistent with the Plan) of any
     option granted hereunder (including but not limited to restrictions upon
     the options, conditions of their exercise, or on the shares of Common Stock
     issuable upon exercise thereof), (5) determine whether nonqualified stock
     options or incentive stock options granted under the Plan shall include
     stock appreciation rights and, if so, shall determine the terms and
     conditions thereof in accordance with Section 6(b)(11) hereof, (6)
     determine whether any nonqualified stock options granted under the Plan
     shall be Associated Options, and (7) prescribe the form of the instruments
     necessary or advisable in the administration of options.
 
          (b) Terms and Conditions of Option. Any option granted under the Plan
     shall be evidenced by a Stock Option Agreement executed by the Company and
     the optionee, in such form as the Committee shall approve, which agreement
     shall be subject to the following terms and conditions and shall contain
     such additional terms and conditions not inconsistent with the Plan, and in
     the case of an incentive stock option not inconsistent with the provisions
     of the Code applicable to incentive stock options, as the Committee shall
     prescribe:
 
             (1) Number of Shares Subject to an Option. The Stock Option
        Agreement shall specify the number of shares of Common Stock subject to
        the Agreement. If the option is an Associated Option, the number of
        shares of Common Stock subject to such Associated Option shall initially
        be equal to the number of performance units or performance shares
        subject to the award, but one share of Common Stock shall be canceled
        for each performance unit or performance share paid out under the award.
 
             (2) Option Price. The purchase price per share of Common Stock
        purchasable under an option will be determined by the Committee but will
        be not less than the Fair Market Value of a share of Common Stock on the
        date of the grant of such option.
 
             (3) Option Period. The period of each option shall be fixed by the
        Committee, but no option shall be exercisable after the expiration of
        ten years from the date the option is granted.
 
             (4) Consideration. Each optionee, as consideration for the grant of
        an option, shall remain in the continuous employ of the Company or of
        one of its Subsidiaries or Affiliates for at least one year from the
        date of the granting of such option, and no option shall be exercisable
        until after the completion of such one year period of employment by the
        optionee.
 
             (5) Exercise of Option. An option may be exercised in whole or in
        part from time to time during the option period (or, if determined by
        the Committee, in specified installments during the option period) by
        giving written notice of exercise to the Company specifying the number
        of shares to be purchased, such notice to be accompanied by payment in
        full of the purchase price and Withholding Taxes (as defined in Section
        11 hereof), unless an election to defer receipt of shares is made under
        Section 12, due either by certified or bank check, or in shares of
        Common Stock of the Company owned by the optionee having a Fair Market
        Value at the date of exercise equal to such purchase price, or in a
        combination of the foregoing; provided, however, that payment in shares
        of Common Stock of the Company will not be permitted unless at least 100
        shares of Common Stock are required and delivered for such purpose. No
        shares shall be issued until full payment therefor has been made. An
        optionee shall have the rights of a stockholder only with respect to
        shares of stock for which certificates have been issued to the optionee.
 
             (6) Nontransferability of Options. No option or stock appreciation
        right granted under the Plan shall be transferable by the optionee
        otherwise than by will or by the laws of descent and distribution, and
        such option or stock appreciation right shall be exercisable, during the
        optionee's lifetime, only by the optionee. Notwithstanding the
        foregoing, the Committee may set forth in a Stock Option Agreement at
        the time of grant or thereafter, that the options
 
                                      B-3
 
<PAGE>

<PAGE>


        (other than Incentive Stock Options) may be transferred to members of
        the optionee's immediate family, to trusts solely for the benefit of
        such immediate family members and to partnerships in which such family
        members and/or trusts are the only partners. For this purpose, immediate
        family means the optionee's spouse, parents, children, stepchildren,
        grandchildren and legal dependants. Any transfer of options made under
        this provision will not be effective until notice of such transfer is
        delivered to the Company.
 
             (7) Retirement and Termination of Employment Other than by Death or
        Disability. If an optionee shall cease to be employed by the Company or
        any of its Subsidiaries or Affiliates for any reason (other than
        termination of employment by reason of death or Disability) after the
        optionee shall have been continuously so employed for one year after the
        granting of the option, the option shall be exercisable only to the
        extent that the optionee was otherwise entitled to exercise it at the
        time of such cessation of employment with the Company, Subsidiary or
        Affiliate, but in no event after the expiration of the option period set
        forth therein except that in the case of cessation of employment other
        than by reason of Retirement or death, the option shall in no event be
        exercisable after the date three months next succeeding such cessation
        of employment. The Plan does not confer upon any optionee any right with
        respect to continuation of employment by the Company or any of its
        Subsidiaries or Affiliates.
 
             (8) Disability of Optionee. An optionee who ceases to be employed
        by reason of Disability shall be treated as though the optionee remained
        in the employ of the Company or a Subsidiary or Affiliate until the
        earlier of (i) cessation of payments under a disability pay plan of the
        Company, Subsidiary or Affiliate, (ii) the optionee's death, or (iii)
        the optionee's 65th birthday.
 
             (9) Death of Optionee. In the event of the death of the optionee
        while in the employ of the Company or of any of its Subsidiaries or
        Affiliates or within whichever period after Retirement or cessation of
        employment of the optionee specified in subsection (7) or (8) is
        applicable, and provided the optionee shall have been continuously so
        employed for one year after the granting of the option, the option shall
        be exercisable by the executors, administrators, legatees or
        distributees of the optionee's estate, as the case may be, at any time
        following death but in no event after the expiration of the option
        period set forth therein and only to the extent that the optionee would
        otherwise have been entitled to exercise it if the optionee were then
        living, except that in the case of the death of an optionee after
        Retirement or other cessation of employment, the option shall in no
        event be exercisable after the later of (i) the date twelve months next
        succeeding such death or (ii) the last day of the period after
        Retirement or other cessation of employment of the optionee specified in
        Section 6(b)(7). In the event any option is exercised by the executors,
        administrators, legatees or distributees of the estate of a deceased
        optionee, the Company shall be under no obligation to issue stock
        thereunder unless and until the Company is satisfied that the person or
        persons exercising the option are the duly appointed legal
        representatives of the deceased optionee's estate or the proper legatees
        or distributees thereof.
 
             (10) Long-Term Performance Awards. The Committee may from time to
        time grant nonqualified stock options under the Plan in conjunction with
        and related to an award of performance units or performance shares made
        under a Long-Term Performance Award as set forth in Section 7(b)(11). In
        such event, notwithstanding any other provision hereof, (i) the number
        of shares to which the Associated Option applies shall initially be
        equal to the number of performance units or performance shares granted
        by the award, but such number of shares shall be reduced on a
        one-share-for-one unit or share basis to the extent that the Committee
        determines pursuant to the terms of the award, to pay to the optionee or
        the optionee's beneficiary the performance units or performance shares
        granted pursuant to such award; and (ii) such Associated Option shall be
        cancelable in the discretion of the Committee, without the consent of
        the optionee, under the conditions and to the extent specified in the
        award.
 
             (11) Stock Appreciation Rights. In the case of any option granted
        under the Plan, either at the time of grant or by amendment of such
        option at any time after such grant there may be
 
                                      B-4
 
<PAGE>

<PAGE>


        included a stock appreciation right which shall be subject to such terms
        and conditions, not inconsistent with the Plan, as the Committee shall
        impose, including the following:
 
                (A) A stock appreciation right shall be exercisable to the
           extent, and only to the extent, that the option in which it is
           included is at the time exercisable, and may be exercised within such
           period only at such time or times as may be determined by the
           Committee;
 
                (B) A stock appreciation right shall entitle the optionee (or
           any person entitled to act under the provisions of subsection (9)
           hereof) to surrender unexercised the option in which the stock
           appreciation right is included (or any portion of such option) to the
           Company and to receive from the Company in exchange therefor that
           number of shares having an aggregate value equal to (or, in the
           discretion of the Committee, less than) the excess of the value of
           one share (provided such value does not exceed such multiple of the
           option price per share as may be specified by the Committee) over the
           option price per share specified in such option times the number of
           shares called for by the option, or portion thereof, which is so
           surrendered. The Committee shall be entitled to cause the Company to
           settle its obligation, arising out of the exercise of a stock
           appreciation right, by the payment of cash equal to the aggregate
           value of the shares the Company would otherwise be obligated to
           deliver or partly by the payment of cash and partly by the delivery
           of shares. Any such election shall be made within 30 business days
           after the receipt by the Committee of written notice of the exercise
           of the stock appreciation right. The value of a share for this
           purpose shall be the Fair Market Value thereof on the last business
           day preceding the date of the election to exercise the stock
           appreciation right;
 
                (C) No fractional shares shall be delivered under this
           subsection (11) but in lieu thereof a cash adjustment shall be made;
 
                (D) If a stock appreciation right included in an option is
           exercised, such option shall be deemed to have been exercised to the
           extent of the number of shares called for by the option or portion
           thereof which is surrendered on exercise of the stock appreciation
           right and no new option may be granted covering such shares under
           this Plan; and
 
                (E) If an option which includes a stock appreciation right is
           exercised, such stock appreciation right shall be deemed to have been
           canceled to the extent of the number of shares called for by the
           option or portion thereof is exercised and no new stock appreciation
           rights may be granted covering such shares under this Plan.
 
             (12) Incentive Stock Options. In the case of any incentive stock
        option granted under the Plan, the aggregate Fair Market Value of the
        shares of Common Stock of the Company (determined at the time of grant
        of each option) with respect to which incentive stock options granted
        under the Plan and any other plan of the Company or its parent or a
        Subsidiary which are exercisable for the first time by an employee
        during any calendar year shall not exceed $100,000 or such other amount
        as may be required by the Code. In any year, the maximum number of
        shares with respect to which incentive stock options may be granted
        shall not exceed 4,000,000 shares.
 
             (13) Rights of Transferee. Notwithstanding anything to the contrary
        herein, if an option has been transferred in accordance with Section
        6(b)(6), the option shall be exercisable solely by the transferee. The
        option shall remain subject to the provisions of the Plan, including
        that it will be exercisable only to the extent that the optionee or
        optionee's estate would have been entitled to exercise it if the
        optionee had not transferred the option. In the event of the death of
        the optionee prior to the expiration of the right to exercise the
        transferred option, the period during which the option shall be
        exercisable will terminate on the date one year following the date of
        the optionee's death. In the event of the death of the transferee prior
        to the expiration of the right to exercise the option, the period during
        which the option shall be exercisable by the executors, administrators,
        legatees and distributees of the transferee's estate, as the case may be
        for a period of one year following the date of the transferee's death
        but in
 
                                      B-5
 
<PAGE>

<PAGE>


        no event be exercisable after the expiration of the option period set
        forth in the Stock Option Agreement. The option shall be subject to such
        other rules as the Committee shall determine.
 
     7. LONG-TERM PERFORMANCE AWARDS: Awards under the Plan shall consist of the
conditional grant to the participants of a specified number of performance units
or performance shares. The conditional grant of a performance unit to a
participant will entitle the participant to receive a specified dollar value,
variable under conditions specified in the award, if the performance objectives
specified in the award are achieved and the other terms and conditions thereof
are satisfied. The conditional grant of a performance share to a participant
will entitle the participant to receive a specified number of shares of Common
Stock of the Company, or the equivalent cash value, if the objective(s)
specified in the award are achieved and the other terms and conditions thereof
are satisfied.
 
     Each award will be subject to the following terms and conditions:
 
          (a) Grant of Awards. The Committee shall (1) select the officers and
     key executives of the Company and its Subsidiaries and Affiliates to whom
     awards may from time to time be granted, (2) determine the number of
     performance units or performance shares covered by each award, (3)
     determine the terms and conditions of each performance unit or performance
     share awarded and the award period and performance objectives with respect
     to each award, (4) determine the periods during which a participant may
     request the Committee to approve deferred payment of a percentage (not less
     than 25%) of an award (the 'Deferred Portion') and the interest or rate of
     return thereon or the basis on which such interest or rate of return
     thereon is to be determined, (5) determine whether payment with respect to
     the portion of an award which has not been deferred (the 'Current Portion')
     and the payment with respect to the Deferred Portion of an award shall be
     made entirely in cash, entirely in Common Stock or partially in cash and
     partially in Common Stock, (6) determine whether the award is to be made
     independently of or in conjunction with a nonqualified stock option granted
     under the Plan, and (7) prescribe the form of the instruments necessary or
     advisable in the administration of the awards.
 
          (b) Terms and Conditions of Award. Any award conditionally granting
     performance units or performance shares to a participant shall be evidenced
     by a Performance Unit Agreement or Performance Share Agreement, as
     applicable, executed by the Company and the participant, in such form as
     the Committee shall approve, which Agreement shall contain in substance the
     following terms and conditions applicable to the award and such additional
     terms and conditions as the Committee shall prescribe:
 
             (1) Number and Value of Performance Units. The Performance Unit
        Agreement shall specify the number of performance units conditionally
        granted to the participant. If the award has been made in conjunction
        with the grant of an Associated Option, the number of performance units
        granted shall initially be equal to the number of shares which the
        participant is granted the right to purchase pursuant to the Associated
        Option, but one performance unit shall be canceled for each share of the
        Company's Common Stock purchased upon exercise of the Associated Option
        or for each stock appreciation right included in such option that has
        been exercised. The Performance Unit Agreement shall specify the
        threshold, target and maximum dollar values of each performance unit and
        corresponding performance objectives as provided under Section 6(b)(5).
        No payout under a performance unit award to an individual Participant
        may exceed 0.15% of the pre-tax earnings of the Company for the fiscal
        year which coincides with the final year of the performance unit period.
 
             (2) Number and Value of Performance Shares. The Performance Share
        Agreement shall specify the number of performance shares conditionally
        granted to the participant. If the award has been made in conjunction
        with the grant of an Associated Option, the number of performance shares
        granted shall initially be equal to the number of shares which the
        participant is granted the right to purchase pursuant to the Associated
        Option, but one performance share shall be canceled for each share of
        the Company's Common Stock purchased upon exercise of the Associated
        Option or for each stock appreciation right included in such option that
        has been exercised. The Performance Share Agreement shall specify that
        each Performance Share will have a value equal to one (1) share of
        Common Stock of the Company.
 
                                      B-6
 
<PAGE>

<PAGE>


             (3) Award Periods. For each award, the Committee shall designate an
        award period with a duration to be determined by the Committee in its
        discretion but in no event less than three calendar years within which
        specified performance objectives are to be attained. There may be
        several award periods in existence at any one time and the duration of
        performance objectives may differ from each other.
 
             (4) Consideration. Each participant, as consideration for the award
        of performance units or performance shares, shall remain in the
        continuous employ of the Company or of one of its Subsidiaries or
        Affiliates for at least one year after the date of the making of such
        award, and no award shall be payable until after the completion of such
        one year of employment by the participant.
 
             (5) Performance Objectives. The Committee shall establish
        performance objectives with respect to the Company for each award period
        on the basis of such criteria and to accomplish such objectives as the
        Committee may from time to time determine. Performance criteria for
        awards under the Plan may include one or more of the following measures
        of the operating performance:
 
<TABLE>
         <S>   <C>                            <C>   <C>
          a.    Earnings                       d.    Financial return ratios
           
          b.    Revenue                        e.    Total Shareholder Return
           
          c.    Operating or net cash flows    f.    Market share

</TABLE>
 
            The Committee shall establish the specific targets for the selected
            criteria. These targets may be set at a specific level or may be
            expressed as relative to the comparable measure at comparison
            companies or a defined index. These targets may be based upon the
            total Company or upon a defined business unit which the executive
            has responsibility for or influence over.
 
             (6) Determination and Payment of Performance Units or Performance
        Shares Earned. As soon as practicable after the end of an award period,
        the Committee shall determine the extent to which awards have been
        earned on the basis of the Company's actual performance in relation to
        the established performance objectives as set forth in the Performance
        Unit Agreement or Performance Share Agreement and certify these results
        in writing. The Performance Unit Agreement or Performance Share
        Agreement shall specify that as soon as practicable after the end of
        each award period, the Committee shall determine whether the conditions
        of Sections 7(b)(4) and 7(b)(5) hereof have been met and, if so, shall
        ascertain the amount payable or shares which should be distributed to
        the participant in respect of the performance units or performance
        shares. As promptly as practicable after it has determined that an
        amount is payable or should be distributed in respect of an award, the
        Committee shall cause the Current Portion of such award to be paid or
        distributed to the participant or the participant's beneficiaries, as
        the case may be, in the Committee's discretion, either entirely in cash,
        entirely in Common Stock or partially in cash and partially in Common
        Stock. The Deferred Portion of an award shall be contingently credited
        and payable to the participant over a deferred period and shall be
        credited with interest, rate of return, or other valuation as determined
        by the Committee. The Committee, in its discretion, shall determine the
        conditions upon, and method of, payment of such Deferred Portions and
        whether such payment will be made entirely in cash, entirely in Common
        Stock or partially in cash and partially in Common Stock.
 
             In making the payment of an award in Common Stock hereunder, the
        cash equivalent of such Common Stock shall be determined by the Fair
        Market Value of the Common Stock on the day the Committee designates the
        performance units shall be payable.
 
             (7) Nontransferability of Awards and Designation of Beneficiaries.
        No award under this Section of the Plan shall be transferable by the
        participant other than by will or by the laws of descent and
        distribution, except that a participant may designate a beneficiary
        pursuant to the provisions hereof.
 
             If any participant or the participant's beneficiary shall attempt
        to assign the participant's rights under the Plan in violation of the
        provisions thereof, the Company's obligation to make
 
                                      B-7
 
<PAGE>

<PAGE>


        any further payments to such participant or the participant's
        beneficiaries shall forthwith terminate.
 
             A participant may name one or more beneficiaries to receive any
        payment of an award to which the participant may be entitled under the
        Plan in the event of the participant's death, on a form to be provided
        by the Committee. A participant may change the participant's beneficiary
        designation from time to time in the same manner.
 
             If no designated beneficiary is living on the date on which any
        payment becomes payable to a participant's beneficiary, or if no
        beneficiary has been specified by the participant, such payment will be
        payable to the person or persons in the first of the following classes
        of successive preference:
 
               (i)  Widow or widower, if then living,
 
               (ii)  Surviving children, equally,
 
               (iii) Surviving parents, equally,
 
               (iv) Surviving brothers and sisters, equally,
 
               (v)  Executors or administrators
 
            and the term 'beneficiary' as used in the Plan shall include such
            person or persons.
 
             (8) Retirement and Termination of Employment Other Than by Death or
        Disability. In the event of the Retirement prior to the end of an award
        period of a participant who has satisfied the one year employment
        requirement of Section 7(b)(4) with respect to an award prior to
        Retirement, the participant, or his estate, shall be entitled to a
        payment of such award at the end of the award period, pursuant to the
        terms of the Plan and the participant's Performance Unit Agreement or
        Performance Share Agreement, provided, however, that the participant
        shall be deemed to have earned that proportion (to the nearest whole
        unit or share) of the value of the performance units or performance
        shares granted to the participant under such award as the number of
        months of the award period which have elapsed since the first day of the
        calendar year in which the award was made to the end of the month in
        which the participant's Retirement occurs, bears to the total number of
        months in the award period, subject to the attainment of performance
        objectives associated with the award as certified by the Committee. The
        participant's right to receive any remaining performance units or
        performance shares shall be canceled and forfeited.
 
             Subject to Section 7(b)(6) hereof, the Performance Unit Agreement
        or Performance Share Agreement shall specify that the right to receive
        the performance units or performance shares granted to such participant
        shall be conditional and shall be canceled, forfeited and surrendered if
        the participant's continuous employment with the Company and its
        Subsidiaries and Affiliates shall terminate for any reason, other than
        the participant's death, Disability or Retirement prior to the end of
        the award period.
 
             (9) Disability of Participant. For the purposes of any award a
        participant who becomes Disabled shall be deemed to have suspended
        active employment by reason of Disability commencing on the date the
        participant becomes entitled to receive payments under a disability pay
        plan of the Company or any Subsidiary or Affiliate and continuing until
        the date the participant is no longer entitled to receive such payments.
        In the event a participant becomes Disabled during an award period but
        only if the participant has satisfied the one year employment
        requirement of Section 7(b)(4) with respect to an award prior to
        becoming Disabled, upon the determination by the Committee of the extent
        to which an award has been earned pursuant to Section 7(b)(6) the
        participant shall be deemed to have earned that proportion (to the
        nearest whole unit) of the value of the performance units granted to the
        participants under such award as the number of months of the award
        period in which the participant was not Disabled bears to the total
        number of months in the award period subject to the attainment of the
        performance objectives associated with the award as certified by the
        Committee. The participant's right to receive any remaining performance
        units shall be canceled and forfeited.
 
                                      B-8
 
<PAGE>

<PAGE>


             (10) Death of Participant. In the event of the death prior to the
        end of an award period of a participant who has satisfied the one year
        employment requirement with respect to an award prior to the date of
        death, the participant's beneficiaries or estate, as the case may be,
        shall be entitled to a payment of such award upon the end of the award
        period, pursuant to the terms of the Plan and the participant's
        Performance Unit Agreement or Performance Share Agreement, provided,
        however, that the participant shall be deemed to have earned that
        proportion (to the nearest whole unit or share) of the value of the
        performance units or performance shares granted to the participant under
        such award as the number of months of the award period which have
        elapsed since the first day of the calendar year in which the award was
        made to the end of the month in which the participant's death occurs,
        bears to the total number of months in the award period. The
        participant's right to receive any remaining performance units or
        performance shares shall be canceled and forfeited.
 
             The Committee may, in its discretion, waive, in whole or in part,
        such cancellation and forfeiture of any performance units or performance
        shares.
 
             (11) Grant of Associated Option. If the Committee determines that
        the conditional grant of performance units or performance shares under
        the Plan is to be made to a participant in conjunction with the grant of
        a nonqualified stock option under the Plan, the Committee shall grant
        the participant an Associated Option under the Plan subject to the terms
        and conditions of this subsection (11). In such event, such award under
        the Plan shall be contingent upon the participant's being granted such
        an Associated Option pursuant to which: (i) the number of shares the
        optionee may purchase shall initially be equal to the number of
        performance units or performance shares conditionally granted by the
        award, (ii) such number of shares shall be reduced on a
        one-share-for-one-unit or share basis to the extent that the Committee
        determines, pursuant to Section 7(b)(6) hereof, to pay to the
        participant or the participant's beneficiaries the performance units or
        performance shares conditionally granted pursuant to the award, and
        (iii) the Associated Option shall be cancelable in the discretion of the
        Committee, without the consent of the participant, under the conditions
        and to the extent specified herein and in Section 7(b)(6) hereof.
 
             If no amount is payable in respect of the conditionally granted
        performance units or performance shares, the award and such performance
        units or performance shares shall be deemed to have been canceled,
        forfeited and surrendered, and the Associated Option, if any, shall
        continue in effect in accordance with its terms. If any amount is
        payable in respect of the performance units or performance shares and
        such units or shares were granted in conjunction with an Associated
        Option, the Committee shall, within 30 days after the determination of
        the Committee referred to in the first sentence of Section 7(b)(6),
        determine, in its sole discretion, either:
 
                (a) to cancel in full the Associated Option, in which event the
           value of the performance units or performance shares payable pursuant
           to Sections 7(b)(5) and (6) shall be paid or the performance shares
           shall be distributed;
 
                (b) to cancel in full the performance units or performance
           shares, in which event no amount shall be paid to the participant in
           respect thereof and no shares shall be distributed but the Associated
           Option shall continue in effect in accordance with its terms; or
 
                (c) to cancel some, but not all, of the performance units or
           performance shares, in which event the value of the performance units
           payable pursuant to Sections 7(b)(5) and (6) which have not been
           canceled shall be paid and/or the performance shares shall be
           distributed and the Associated Option shall be canceled with respect
           to that number of shares equal to the number of conditionally granted
           performance units or performance shares that remain payable.
 
             Any action taken by the Committee pursuant to the preceding
        sentence shall be uniform with respect to all awards having the same
        award period. If the Committee takes no such
 
                                      B-9
 
<PAGE>

<PAGE>


        action, it shall be deemed to have determined to cancel in full the
        award in accordance with clause (b) above.
 
     8. RESTRICTED STOCK: Restricted stock awards under the Plan shall consist
of grants of shares of Common Stock of the Issuer subject to the terms and
conditions hereinafter provided.
 
     (a) Grant of Awards: The Committee shall (i) select the officers and key
employees to whom Restricted Stock may from time to time be granted, (ii)
determine the number of shares to be covered by each award granted, (iii)
determine the terms and conditions (not inconsistent with the Plan) of any award
granted hereunder, and (iv) prescribe the form of the agreement, legend or other
instrument necessary or advisable in the administration of awards under the
Plan.
 
     (b) Terms and Conditions of Awards: Any restricted stock award granted
under the Plan shall be evidenced by a Restricted Stock Agreement executed by
the Issuer and the recipient, in such form as the Committee shall approve, which
agreement shall be subject to the following terms and conditions and shall
contain such additional terms and conditions not inconsistent with the Plan as
the Committee shall prescribe:
 
          (1) Number of Shares Subject to an Award: The Restricted Stock
     Agreement shall specify the number of shares of Common Stock subject to the
     Award.
 
          (2) Restriction Period: The period of restriction applicable to each
     Award shall be established by the Committee but may not be less than one
     year. The Restriction Period applicable to each Award shall commence on the
     Award Date.
 
          (3) Consideration: Each recipient, as consideration for the grant of
     an award, shall remain in the continuous employ of the Company for at least
     one year from the date of the granting of such award, and any shares
     covered by such an award shall lapse if the recipient does not remain in
     the continuous employ of the Company for at least one year from the date of
     the granting of the award.
 
          (4) Restriction Criteria: The Committee shall establish the criteria
     upon which the restriction period shall be based. Restrictions may be based
     upon either the continued employment of the recipient or upon the
     attainment by the Company of one or more of the following measures of the
     operating performance:
 
<TABLE>
<S>  <C>                             <C>  <C>
a.   Earnings                        d.   Financial return ratios
 
b.   Revenue                         e.   Total Shareholder Return
 
c.   Operating or net cash flows     f.   Market share
</TABLE>
 
     The Committee shall establish the specific targets for the selected
criteria. These targets may be set at a specific level or may be expressed as
relative to the comparable measure at comparison companies or a defined index.
Performance objectives may be established in combination with restrictions based
upon the continued employment of the recipient. These targets may be based upon
the total Company or upon a defined business unit which the executive has
responsibility for or influence over.
 
     In cases where objective performance criteria are established, the
Committee shall determine the extent to which the criteria have been achieved
and the corresponding level to which restrictions will be removed from the Award
or the extent to which a participant's right to receive an Award should be
lapsed in cases where the performance criteria have not been met and shall
certify these determinations in writing. The Committee may provide for the
determination of the attainment of such restrictions in installments where
deemed appropriate.
 
     (c) Terms and Conditions of Restrictions and Forfeitures: The shares of
Common Stock awarded pursuant to the Plan shall be subject to the following
restrictions and conditions:
 
          (1) During the Restriction Period, the participant will not be
     permitted to sell, transfer, pledge or assign Restricted Stock awarded
     under this Plan.
 
          (2) Except as provided in Section 8(c)(i), or as the Committee may
     otherwise determine, the participant shall have all of the rights of a
     stockholder of the Issuer, including the right to vote the shares and
     receive dividends and other distributions provided that distributions in
     the form of stock shall be subject to the same restrictions as the
     underlying Restricted Stock.
 
                                      B-10
 
<PAGE>

<PAGE>


          (3) In the event of a participant's retirement, death or disability
     prior to the end of the Restriction Period for a participant who has
     satisfied the one year employment requirement of Section 7(c)(iii) with
     respect to an award prior to Retirement, death or Disability, the
     participant, or his/her estate, shall be entitled to receive that
     proportion (to the nearest whole share) of the number of shares subject to
     the Award granted as the number of months of the Restriction Period which
     have elapsed since the Award date to the date at which the participant's
     retirement, death or disability occurs, bears to the total number of months
     in the Restriction Period. The participant's right to receive any remaining
     shares shall be canceled and forfeited and the shares will be deemed to be
     reacquired by the Issuer.
 
          (4) In the event of a participant's retirement, death, disability or
     in cases of special circumstances as determined by the Committee, the
     Committee may, in its sole discretion when it finds that such an action
     would be in the best interests of the Company, accelerate or waive in whole
     or in part any or all remaining time based restrictions with respect to all
     or part of such participant's Restricted Stock.
 
          (5) Upon termination of employment for any reason during the
     restriction period, subject to the provisions of paragraph (iii) above or
     in the event that the participant fails promptly to pay or make
     satisfactory arrangements as to the withholding taxes as provided in the
     following paragraph, all shares still subject to restriction shall be
     forfeited by the participant and will be deemed to be reacquired by the
     Company.
 
          (6) A participant may, at any time prior to the expiration of the
     Restriction Period, waive all right to receive all or some of the shares of
     a Restricted Stock Award by delivering to the Company a written notice of
     such waiver.
 
          (7) Notwithstanding the other provisions of this Section 7, the
     Committee may adopt rules which would permit a gift by a participant of
     restricted shares to members of his/her immediate family (spouse, parents,
     children, stepchildren, grandchildren or legal dependants) or to a Trust
     whose beneficiary or beneficiaries shall be either such a person or persons
     or the participant.
 
          (8) Any attempt to dispose of Restricted Stock in a manner contrary to
     the restrictions shall be ineffective.
 
     9. DETERMINATION OF BREACH OF CONDITIONS: The determination of the
Committee as to whether an event has occurred resulting in a forfeiture or a
termination or reduction of the Company's obligations in accordance with the
provisions of the Plan shall be conclusive.
 
     10. ADJUSTMENT IN THE EVENT OF CHANGE IN STOCK: In the event of changes in
the outstanding Common Stock of the Company by reason of stock dividends,
recapitalization, mergers, consolidations, split-ups, combinations or exchanges
of shares and the like, the aggregate number and class of shares available under
the Plan, and the number, class and the price of shares subject to outstanding
options and/or awards and the number of performance units and/or the dollar
value of each unit shall be appropriately adjusted by the Committee, whose
determination shall be conclusive.
 
     11. TAXES: Each participant shall, no later than the Tax Date (as defined
below), pay to the Company, or make arrangements satisfactory to the Committee
regarding payment of, any Withholding Tax (as defined below) with respect to an
Option or Award, and the Company shall, to the extent permitted by law, have the
right to deduct such amount from any payment of any kind otherwise due to the
participant. The Company shall also have the right to retain or sell without
notice, or to demand surrender of, shares of Common Stock in value sufficient to
cover the amount of any Withholding Tax (that is that portion of any Applicable
Tax, as defined below, required by any governmental entity to be withheld or
otherwise deducted and paid with respect to such Award), and to make payment (or
to reimburse itself for payment made) to the appropriate taxing authority of an
amount in cash equal to the amount of such Withholding Tax, remitting any
balance to the participant. For purposes of the paragraph, the value of shares
of Common Stock so retained or surrendered shall be the average of the high and
low sales prices per share on the New York Stock Exchange composite tape on the
date that the amount of the Withholding Tax is to be determined (the 'Tax Date')
and the value of shares of Common Stock so sold shall be the actual net sale
price per share (after deduction of commissions) received by the Company.
Notwithstanding the foregoing, if the stock options have been transferred, the
 
                                      B-11
 
<PAGE>

<PAGE>


optionee shall provide the Company with funds sufficient to pay such
Withholding Tax or Applicable Tax. Furthermore, if such optionee does not
satisfy his tax payment obligation and the stock options have been transferred,
the transferree may provide the funds sufficient to enable the Company to pay
such taxes. However, if the stock options have been transferred, the Company
shall have no right to retain or sell without notice, or to demand surrender
from the transferree of, the shares of Common Stock in order to pay such
Withholding Tax or Applicable Tax.
 
     Notwithstanding the foregoing, the participant shall be entitled to satisfy
the obligation to pay any Withholding Tax or to satisfy the obligation to pay
any tax to any governmental entity in respect of such Award, including any
Federal, state or local income tax up to an amount determined on the basis of
the highest marginal tax rate applicable to such participant, Federal Insurance
Contribution Act taxes or other governmental impost or levy (an 'Applicable
Tax'), in whole or in part, by providing the Company with funds sufficient to
enable the Company to pay such Withholding Tax or Applicable Tax or by requiring
the Company to retain or to accept upon delivery thereof by the participant
shares of Common Stock having a Fair Market Value sufficient to cover the amount
of such Withholding Tax or Applicable Tax or in a greater amount as deemed
appropriate by the Company. Each election by a participant to have shares
retained or to deliver shares for this purpose shall be subject to the following
restrictions: (i) the election must be in writing and be made on or prior to the
Tax Date; (ii) the election must be irrevocable; (iii) the election shall be
subject to the disapproval of the Committee.
 
     12. DEFERRAL ELECTION: Notwithstanding the provisions of Section 11, any
optionee or participant may elect, with the concurrence of the Committee and
consistent with any rules and regulations established by the Committee, to defer
the delivery of the proceeds of the exercise of any stock option not transferred
under the provisions of Section 6(b)(6) or stock appreciation rights.
 
          (a) Election Timing: The election to defer the delivery of the
     proceeds from any eligible award must be made at least six months prior to
     the date such award is exercised or at such other time as the Committee may
     specify. Deferrals will only be allowed for exercises which occur while the
     optionee or participant is an active employee of the Company. Any election
     to defer the delivery of proceeds from an eligible award shall be
     irrevocable as long as the optionee or participant remains an employee of
     the Company.
 
          (b) Stock Option Deferral: The deferral of the proceeds of stock
     options may be elected by an optionee subject to the Regulations
     established by the Committee. The proceeds from such an exercise shall be
     credited to the optionee's deferred stock option account as the number of
     deferred share units equivalent in value to those proceeds. Deferred share
     units shall be valued at the Fair Market Value on the date of exercise.
     Subsequent to exercise, the deferred share units shall be valued at the
     Fair Market Value of Common Stock of the Company. Deferred share units
     shall accrue dividends at the rate paid upon the Company's Common Stock
     credited in the form of additional deferred share units. Deferred share
     units shall be distributed in shares of Company Stock upon the termination
     of employment of the participant or at such other date as may be approved
     by the Committee over a period of no more than 10 years.
 
          (c) Stock Appreciation Right Deferral: Upon such exercise, the Company
     will credit the optionee's deferred stock option account with the number of
     deferred share units equivalent in value to the difference between the Fair
     Market Value of a share of Common Stock on the exercise date and the
     exercise price of the Stock Appreciation Right multiplied by the number of
     shares exercised. Deferred share units shall be valued at the Fair Market
     Value on the date of exercise. Subsequent to exercise, the deferred share
     units shall be valued at the Fair Market Value of Common Stock of the
     Company. Deferred share units shall accrue dividends at the rate paid upon
     the Company's Common Stock credited in the form of additional deferred
     share units. Deferred share units shall be distributed in shares of Common
     Stock upon the termination of employment of the participant or at such
     other date as may be approved by the Committee over a period of no more
     than 10 years.
 
          (d) Accelerated Distributions: The Committee may, at its sole
     discretion, allow for the early payment of an optionee's or participant's
     deferred share units account in the event of an 'unforeseeable emergency'
     or in the event of the death or disability of the optionee or participant.
     An 'unforeseeable emergency' is defined as an unanticipated emergency
     caused by an event
 
                                      B-12
 
<PAGE>

<PAGE>


     beyond the control of the optionee or participant that would result in
     severe financial hardship if the distribution were not permitted. Such
     distributions shall be limited to the amount necessary to sufficiently
     address the financial hardship. Any distributions under this provision
     shall be consistent with the Regulations established under the Code.
     Additionally, the Committee may use its discretion to cause deferred share
     unit accounts to be distributed when continuing the Program is no longer in
     the best interest of the Company.
 
          (e) Assignability: No rights to deferred share unit accounts may be
     assigned or subject to any encumbrance, pledge or charge of any nature
     except that an optionee or participant may designate a beneficiary pursuant
     to any rules established by the Committee.
 
     13. AMENDMENT OF THE PLAN: The Board of Directors may amend or suspend the
Plan at any time and from time to time. No such amendment of the Plan may,
however, increase the maximum number of shares to be offered under options or
awards, or change the manner of determining the option price, or change the
designation of employees or class of employees eligible to receive options or
awards, or permit the transfer or issue of stock before payment therefor in
full, or, without the written consent of the optionee or participant, alter or
impair any option or award previously granted under the Plan or Prior Plan.
Notwithstanding the foregoing, if an option has been transferred in accordance
with Section 6(b)(6), written consent of the transferee (and not the optionee)
shall be necessary to alter or impair any option or award previously granted
under the Plan.
 
     14. MISCELLANEOUS:
 
          (a) By accepting any benefits under the Plan, each optionee or
     participant and each person claiming under or through such optionee or
     participant shall be conclusively deemed to have indicated acceptance and
     ratification of, and consent to, any action taken or made to be taken or
     made under the Plan by the Company, the Board, the Committee or any other
     Committee appointed by the Board.
 
          (b) No participant or any person claiming under or through him shall
     have any right or interest, whether vested or otherwise, in the Plan or in
     any option, or stock appreciation right or award thereunder, contingent or
     otherwise, unless and until all of the terms, conditions and provisions of
     the Plan and the Agreement that affect such participant or such other
     person shall have been complied with.
 
          (c) Nothing contained in the Plan or in any Agreement shall require
     the Company to segregate or earmark any cash or other property.
 
          (d) Neither the adoption of the Plan nor its operation shall in any
     way affect the rights and powers of the Company or any of its Subsidiaries
     or Affiliates to dismiss and/or discharge any employee at any time.
 
          (e) Notwithstanding anything to the contrary in the Plan, neither the
     Board nor the Committee shall have any authority to take any action under
     the Plan where such action would affect the Company's ability to account
     for any business combination as a 'pooling of interests.'
 
     15. TERM OF THE PLAN: The Plan, if approved by stockholders, will be
effective May 6, 1997. The Plan shall expire on May 31, 2002 unless suspended or
discontinued by action of the Board of Directors. The expiration of the Plan,
however, shall not affect the rights of Optionees under options theretofore
granted to them or the rights of participants under awards theretofore granted
to them, and all unexpired options and awards shall continue in force and
operation after termination of the Plan except as they may lapse or be
terminated by their own terms and conditions.
 
                                      B-13





© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission